Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 51.7 CHF 0.98%
Market Cap: 702.9m CHF
Have any thoughts about
Medartis Holding AG?
Write Note

Operating Margin
Medartis Holding AG

4.4%
Current
4%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
4.4%
=
Operating Profit
9.6m
/
Revenue
220.3m

Operating Margin Across Competitors

Country CH
Market Cap 702.1m CHF
Operating Margin
4%
Country JP
Market Cap 6.9T JPY
Operating Margin
28%
Country CH
Market Cap 37.7B CHF
Operating Margin
13%
Country DK
Market Cap 179.1B DKK
Operating Margin
27%
Country US
Market Cap 15.8B USD
Operating Margin
17%
Country CN
Market Cap 52B CNY
Operating Margin
45%
Country CA
Market Cap 6.3B USD
Operating Margin
4%
Country KR
Market Cap 9.1T KRW
Operating Margin
-245%
Country US
Market Cap 6.2B USD
Operating Margin
32%
Country US
Market Cap 5.7B USD
Operating Margin
12%
Country UK
Market Cap 4.5B GBP
Operating Margin
13%
No Stocks Found

Medartis Holding AG
Glance View

Market Cap
702.1m CHF
Industry
Health Care

Medartis Holding AG operates as a medical device company. The company is headquartered in Basel, Basel-Stadt and currently employs 684 full-time employees. The company went IPO on 2018-03-23. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. The company has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

MED Intrinsic Value
80.96 CHF
Undervaluation 36%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
4.4%
=
Operating Profit
9.6m
/
Revenue
220.3m
What is the Operating Margin of Medartis Holding AG?

Based on Medartis Holding AG's most recent financial statements, the company has Operating Margin of 4.4%.